Clinical trials recruiting for Cancer
140
Recruiting trials
47
US states with sites
44
Countries
16%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Pembrolizumab | 3 |
| Bevacizumab | 2 |
| Cetuximab | 2 |
| Nivolumab | 2 |
| A2B395 | 1 |
| A2B543 | 1 |
| A2B694 | 1 |
| AGX101 | 1 |
| ALTA3263 | 1 |
| Atezolizumab | 1 |
| Biological samples collection | 1 |
| Blood sampling | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 22 |
| California | 20 |
| Texas | 20 |
| Massachusetts | 12 |
| Pennsylvania | 12 |
| New York | 11 |
| North Carolina | 10 |
| Tennessee | 10 |
| Minnesota | 9 |
| Missouri | 9 |
| Ohio | 9 |
| Virginia | 9 |
Top cities
Los Angeles, California 13Boston, Massachusetts 11Houston, Texas 11Nashville, Tennessee 9New York, New York 9Pittsburgh, Pennsylvania 9St Louis, Missouri 9Fairfax, Virginia 7Jacksonville, Florida 7Columbus, Ohio 6
Self-screener
Recruiting trials
- A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
- A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
- A Natural History Study of Metabolic Sizing in Health and Disease
- A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
- A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
- A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
- A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
- A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
- A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch
- Analysis of Circulating Tumor Markers in Blood
- Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
- AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC)
- Autologous Testicular Tissue Transplantation
- Avera Cancer Sequencing and Analytics Protocol (ASAP)
- BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS
- Biograph Vision 600 Versus Biograph Vision.X PET/CT
- Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
- Breast Re-irradiation After Second Ipsilateral Lumpectomy
- Breathlessness Patterns in Patients With Cancer, COPD and Heart Failure: an fMRI Feasibility Study
- Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Circulating Tumour DNA (ctDNA) in Patients With Colorectal Cancer and the Relationship to Imaging Features of Extramural Venous Invasion
- Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
- Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
- DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
- DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
- DST in Reducing Depressive Symptoms, Enhancing Self-esteem, and Promoting Quality of Life Among CCSs
- Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer
- Domestication and Implementation of the PEN-Plus Clinical Model in the Zambian Health System
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality
- EXCEL: Exercise for Cancer to Enhance Living Well
- EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer
- Early Ageing During Therapy in AYA Cancer Patients
- Effects of Online Yoga on the Quality of Life of Breast Cancer Patients
- Electroacupuncture on Treating Cancer-related Depression
- Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)
- Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
- Evaluation of a Mobile App Program for Coping With Cancer
- Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer
- FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Feasibility of a Technology-Based Intervention for Depression Referral Uptake in Cancer Survivors
- First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic Cancer
- GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer
- GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers
- Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis
- Genomic Investigation of Unusual Responders
- Glasgow Low-dose CT and AI-based Diagnostics to Case Find Lung Cancer and Other Cardio-respiratory Long-term Conditions - Feasibility Study
- HER2+ CNS Surveillance
- Hamburg City Health Study - a German Cohort Study
- Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data
- Healthy Living Anson Study
- Heuristics, Algorithms and Machine Learning: Evaluation & Testing in Radiation Therapy
- IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
- Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated With Immunotherapy and Chemotherapy in the Maintenance Phase
- Improving Engagement in HIV and Cancer Care in Zimbabwe
- Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care
- Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers
- Interprofessional Pharmacogenomics (IPGx) Registry and Repository
- Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
- Investigating Real-Time Immunotherapy Symptoms Study
- LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
- LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer
- Liquid Biopsy Evaluation and Repository Development at Princess Margaret
- Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing
- Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
- My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of Life
- Nanshan Elderly Cohort Study
- On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety
- Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
- Optimizing Care for Cancer Survivors With Depression: Project 3
- Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
- Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication
- Patient Anxiety During Magnetic Resonance Imaging
- Pharmaceutical Management in Targeted Radioligand Therapy
- Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors
- Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Phase I Human Analytics (HALO) Study
- Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
- Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
- Positron Emission Tomography (PET) Imaging of Thrombosis
- Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test
- Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA
- Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
- Preoperative Radiation Therapy and Immediate Breast Reconstruction
- Prognostic Value of Neurometabolic Networks in CRC (PVNM-CRC)
- Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
- Prospective Urban Rural Epidemiology Study
- Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
- Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
- Psychoneurological Symptom Cluster in Oncology
Related conditions
Trials recruiting for Cancer often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Breast cancer 2239Colorectal cancer 1359Prostate cancer 1234Melanoma 487Pancreatic cancer 870Depression 1463Anxiety 1237Ovarian cancer 118Obesity 1512
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.